These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 24330206)

  • 1. Prognostic factors for risk stratification of adult cancer patients with chemotherapy-induced febrile neutropenia: a systematic review and meta-analysis.
    Lee YM; Lockwood C
    Int J Nurs Pract; 2013 Dec; 19(6):557-76. PubMed ID: 24330206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors for risk stratification of adult cancer patients with chemotherapy-induced febrile neutropenia: a systematic review and meta-analysis.
    Lee YM; Lang D; Lockwood C
    JBI Libr Syst Rev; 2012; 10(40):2593-2657. PubMed ID: 27820557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy of the Multinational Association of Supportive Care in Cancer (MASCC) and Clinical Index of Stable Febrile Neutropenia (CISNE) scores for predicting serious complications in adult patients with febrile neutropenia: A systematic review and meta-analysis.
    Zheng B; Toarta C; Cheng W; Taljaard M; Reaume N; Perry JJ
    Crit Rev Oncol Hematol; 2020 May; 149():102922. PubMed ID: 32244162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of the MASCC and CISNE Risk-Stratification Scores to Identify Low-Risk Febrile Neutropenic Patients in the Emergency Department.
    Coyne CJ; Le V; Brennan JJ; Castillo EM; Shatsky RA; Ferran K; Brodine S; Vilke GM
    Ann Emerg Med; 2017 Jun; 69(6):755-764. PubMed ID: 28041827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical analysis of febrile neutropenia in urological anticancer chemotherapy: retrospective single center study.
    Nishiyama N; Takahashi S; Mizuno T; Uehara T; Hashimoto J; Kurimura Y; Masumori N
    Int J Clin Oncol; 2015 Oct; 20(5):1012-7. PubMed ID: 25652906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing Symptoms and Management of Febrile Neutropenia among Cancer Patients: Current Status and Future Directions.
    Wang XJ; Chan A
    Curr Oncol Rep; 2017 Mar; 19(3):20. PubMed ID: 28271398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Initial management of febrile neutropenia].
    Badertscher L; Damak H; Mercier L; Décosterd D
    Rev Med Suisse; 2016 Aug; 12(526):1321-1325. PubMed ID: 28671776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common misconceptions in the prognostic evaluation of clinically stable patients with febrile neutropenia and solid tumors.
    Carmona-Bayonas A; Jiménez-Fonseca P
    Clin Transl Oncol; 2019 Aug; 21(8):1112-1114. PubMed ID: 30607791
    [No Abstract]   [Full Text] [Related]  

  • 9. Risk-stratification management of febrile neutropenia in pediatric hematology-oncology patients: Results of a French nationwide survey.
    Delebarre M; Tiphaine A; Martinot A; Dubos F
    Pediatr Blood Cancer; 2016 Dec; 63(12):2167-2172. PubMed ID: 27569451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The incidence and risk factors of febrile neutropenia in chemotherapy-naïve lung cancer patients receiving etoposide plus platinum.
    Fujiwara T; Kenmotsu H; Naito T; Kawamura T; Mamesaya N; Kotake M; Kobayashi H; Omori S; Nakashima K; Wakuda K; Ono A; Taira T; Murakami H; Omae K; Mori K; Endo M; Takahashi T
    Cancer Chemother Pharmacol; 2017 Jun; 79(6):1229-1237. PubMed ID: 28455585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Febrile Neutropenia.
    Patel K; West HJ
    JAMA Oncol; 2017 Dec; 3(12):1751. PubMed ID: 28750112
    [No Abstract]   [Full Text] [Related]  

  • 12. Predictive factors for poor prognosis febrile neutropenia.
    Ahn S; Lee YS
    Curr Opin Oncol; 2012 Jul; 24(4):376-80. PubMed ID: 22476191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective cohort study of febrile neutropenia in breast cancer patients with neoadjuvant and adjuvant chemotherapy: CSPOR-BC FN study.
    Ishikawa T; Sakamaki K; Narui K; Kaise H; Tsugawa K; Ichikawa Y; Mukai H;
    Jpn J Clin Oncol; 2016 Jul; 46(7):692-5. PubMed ID: 27162322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer chemotherapy treatment patterns and febrile neutropenia in the US Veterans Health Administration.
    Wang L; Barron R; Baser O; Langeberg WJ; Dale DC
    Value Health; 2014 Sep; 17(6):739-43. PubMed ID: 25236998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of serious complications in patients with seemingly stable febrile neutropenia: validation of the Clinical Index of Stable Febrile Neutropenia in a prospective cohort of patients from the FINITE study.
    Carmona-Bayonas A; Jiménez-Fonseca P; Virizuela Echaburu J; Antonio M; Font C; Biosca M; Ramchandani A; Martínez J; Hernando Cubero J; Espinosa J; Martínez de Castro E; Ghanem I; Beato C; Blasco A; Garrido M; Bonilla Y; Mondéjar R; Arcusa Lanza MÁ; Aragón Manrique I; Manzano A; Sevillano E; Castañón E; Cardona M; Gallardo Martín E; Pérez Armillas Q; Sánchez Lasheras F; Ayala de la Peña F
    J Clin Oncol; 2015 Feb; 33(5):465-71. PubMed ID: 25559804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granulocyte colony-stimulating factors in the prevention of febrile neutropenia: review of cost-effectiveness models.
    Fust K; Parthan A; Maschio M; Gu Q; Li X; Lyman GH; Tzivelekis S; Villa G; Weinstein MC
    Expert Rev Pharmacoecon Outcomes Res; 2017 Feb; 17(1):39-52. PubMed ID: 28064553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The suggestion of a risk stratification system for febrile neutropenia in patients with hematologic disease.
    Park Y; Kim DS; Park SJ; Seo HY; Lee SR; Sung HJ; Park KH; Choi IK; Kim SJ; Oh SC; Seo JH; Choi CW; Kim BS; Shin SW; Kim YH; Kim JS
    Leuk Res; 2010 Mar; 34(3):294-300. PubMed ID: 19762083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Febrile Neutropenia Rates According to Body Mass Index and Dose Capping in Women Receiving Chemotherapy for Early Breast Cancer.
    Lote H; Sharp A; Redana S; Papadimitraki E; Capelan M; Ring A
    Clin Oncol (R Coll Radiol); 2016 Sep; 28(9):597-603. PubMed ID: 26936608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.
    Moghnieh R; Estaitieh N; Mugharbil A; Jisr T; Abdallah DI; Ziade F; Sinno L; Ibrahim A
    Front Cell Infect Microbiol; 2015; 5():11. PubMed ID: 25729741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Modalities of management of cancer patients with febrile neutropenia in the oncology emergency unit of Gustave-Roussy and their related costs].
    Borget I; Antoun S; Chachaty E; Gachot B; Alibay A; Di Palma M; Merad M
    Bull Cancer; 2014 Oct; 101(10):925-31. PubMed ID: 25373692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.